Pharma channel feed

No­var­tis touts Zol­gens­ma da­ta in old­er kids as it read­ies reg­u­la­to­ry fil­ings

3 months ago

Gilead stock slips as HHS de­nies re­ports of HIV fund­ing cuts

3 months ago
Law

Ahead of FDA de­ci­sion, Al­ny­lam faces the big ques­tion: Can it make mon­ey?

3 months ago
FDA+
In Focus

Pfiz­er ful­ly ex­its Sen­so­dyne mak­er Ha­le­on in $3.3B stake sale

3 months ago

HHS keeps pro­ba­tion­ary work­ers on ad­min­is­tra­tive leave af­ter court or­der

3 months ago
Law

Six­teen-year-old dies af­ter re­ceiv­ing Sarep­ta’s Duchenne gene ther­a­py

3 months ago
Cell/Gene Tx

Up­dat­ed: No­var­tis re­vamps car­dio­vas­cu­lar com­mer­cial strat­e­gy as En­tresto patent cliff looms 

3 months ago
People

Trump’s HHS de­fends Biden-era stance on 340B re­bate mod­els

3 months ago
Law

WuXi AppTec's US rev­enue growth con­tin­ues to dip in post-Biose­cure en­vi­ron­ment

3 months ago
China
Manufacturing

As­traZeneca re­ports Phase 3 suc­cess for rare dis­ease drug at heart of Amolyt deal

3 months ago
R&D

All se­lect­ed drug­mak­ers agree to sec­ond round of price ne­go­ti­a­tions un­der the IRA

3 months ago
FDA+

Post-Hoc: Kennedy's an­ti-vac­cine ac­tions should­n't sur­prise any­one

3 months ago
FDA+

Ot­suka's Tai­ho buys Swiss start­up Araris with three AD­Cs near­ing the clin­ic

3 months ago
Startups
Deals

Avid­i­ty seeks to 'set the stan­dard' as it heads to FDA with Duchenne drug

3 months ago
R&D

'It’s the law’: Dr. Oz says he would de­fend Medicare drug price ne­go­ti­a­tions

3 months ago
FDA+

Fed­er­al Cir­cuit rul­ing al­lows Am­gen's Eylea biosim­i­lar to stay on the mar­ket

3 months ago
Law

UK's plan to hike drug­mak­er re­bates re­flects 'bro­ken' sys­tem, phar­ma group says

3 months ago

Re­ci­pharm hits record rev­enue for 2024, eyes GLP-1 con­tracts for growth 

3 months ago
Manufacturing

RFK Jr. con­vened round­table around ways to re­duce stem cell reg­u­la­tion

3 months ago
Cell/Gene Tx

Sutro slash­es work­force in half, changes CEO and clos­es fac­to­ry

3 months ago
People
Manufacturing

Moon­Lake's CEO on its loom­ing mid-year piv­otal read­out in skin dis­ease

3 months ago

Pfiz­er ter­mi­nates an ear­ly-stage STING ag­o­nist tri­al

3 months ago
R&D

Up­dat­ed: White House pulls Wel­don's nom­i­na­tion to lead CDC at last minute

3 months ago
FDA+

Am­gen re­ports more Up­liz­na da­ta in myas­the­nia gravis ahead of FDA fil­ing

3 months ago
R&D
First page Previous page 14151617181920 Next page Last page
A service from the Financial Times